Margarida Serra

Dr. Margarida Serra


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Trends in Biotechnology
Verified
Journal Article
Closed access
MSMargarida Serra
Margarida Serra
Catarina BritoCatarina Brito
Catarina Brito
CCCláudia Correia
Cláudia Correia
PAPaula M Alves
Paula M Alves

1 April 2012 in Hepatology
Verified
Journal Article
Closed access
PDF file
RTRui M. Tostões
Rui M. Tostões
SLSofia B. Leite
Sofia B. Leite
MSMargarida Serra
Margarida Serra
JJJanne Jensen
Janne Jensen
PBPetter Björquist
Petter Björquist
PAPaula M Alves
Paula M Alves

17 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CCCláudia Correia
Cláudia Correia
AKAlexey Koshkin
Alexey Koshkin
PDPatrícia Duarte
Patrícia Duarte
DHDongjian Hu
Dongjian Hu
ATAna Teixeira
Ana Teixeira
PAPaula M Alves
Paula M Alves
The immature phenotype of human pluripotent stem cell derived cardiomyocytes (hPSC-CMs) constrains their potential in cell therapy and drug testing. In this study, we report that shifting hPSC-CMs from glucose-containing to galactose- and fatty acid-containing medium promotes their fast maturation into adult-like CMs with higher oxidative metabolism, transcriptional signatures closer to those of adult ventricular tissue, higher myofibril density and alignment, improved calcium handling, enhanced contractility, and more physiological action potential kinetics. Integrated “-Omics” analyses showed that addition of galactose to culture medium improves total oxidative capacity of the cells and ameliorates fatty acid oxidation avoiding the lipotoxicity that results from cell exposure to high fatty acid levels. This study provides an important link between substrate utilization and functional maturation of hPSC-CMs facilitating the application of this promising cell type in clinical and preclinical applications.

12 October 2018 in Circulation Research
Verified
Journal Article
Closed access
DHDongjian Hu
Dongjian Hu
ALAnnet Linders
Annet Linders
AYAbir Yamak
Abir Yamak
CCCláudia Correia
Cláudia Correia
JKJan David Kijlstra
Jan David Kijlstra
IDIbrahim J. Domian
Ibrahim J. Domian
Rationale:: Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are a readily available, robustly reproducible, and physiologically appropriate human cell source for cardiac disease modeling, drug discovery, and toxicity screenings in vitro. However, unlike adult myocardial cells in vivo, hPSC-CMs cultured in vitro maintain an immature metabolic phenotype, where majority of ATP is produced through aerobic glycolysis instead of oxidative phosphorylation in the mitochondria. Little is known about the underlying signaling pathways controlling hPSC-CMs’ metabolic and functional maturation. Objective:: To define the molecular pathways controlling cardiomyocytes’ metabolic pathway selections and improve cardiomyocyte metabolic and functional maturation. Methods and Results:: We cultured hPSC-CMs in different media compositions including glucose-containing media, glucose-containing media supplemented with fatty acids, and glucose-free media with fatty acids as the primary carbon source. We found that cardiomyocytes cultured in the presence of glucose used primarily aerobic glycolysis and aberrantly upregulated HIF1α (hypoxia-inducible factor 1α) and its downstream target lactate dehydrogenase A. Conversely, glucose deprivation promoted oxidative phosphorylation and repressed HIF1α. Small molecule inhibition of HIF1α or lactate dehydrogenase A resulted in a switch from aerobic glycolysis to oxidative phosphorylation. Likewise, siRNA inhibition of HIF1α stimulated oxidative phosphorylation while inhibiting aerobic glycolysis. This metabolic shift was accompanied by an increase in mitochondrial content and cellular ATP levels. Furthermore, functional gene expressions, sarcomere length, and contractility were improved by HIF1α/lactate dehydrogenase A inhibition. Conclusions:: We show that under standard culture conditions, the HIF1α-lactate dehydrogenase A axis is aberrantly upregulated in hPSC-CMs, preventing their metabolic maturation. Chemical or siRNA inhibition of this pathway results in an appropriate metabolic shift from aerobic glycolysis to oxidative phosphorylation. This in turn improves metabolic and functional maturation of hPSC-CMs. These findings provide key insight into molecular control of hPSC-CMs’ metabolism and may be used to generate more physiologically mature cardiomyocytes for drug screening, disease modeling, and therapeutic purposes.

5 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMargarida Serra
Margarida Serra
CCCláudia Correia
Cláudia Correia
RMRita Malpique
Rita Malpique
Catarina BritoCatarina Brito
Catarina Brito
JJJanne Jensen
Janne Jensen
PAPaula M Alves
Paula M Alves
The successful implementation of human embryonic stem cells (hESCs)-based technologies requires the production of relevant numbers of well-characterized cells and their efficient long-term storage. In this study, cells were microencapsulated in alginate to develop an integrated bioprocess for expansion and cryopreservation of pluripotent hESCs. Different three-dimensional (3D) culture strategies were evaluated and compared, specifically, microencapsulation of hESCs as: i) single cells, ii) aggregates and iii) immobilized on microcarriers. In order to establish a scalable bioprocess, hESC-microcapsules were cultured in stirred tank bioreactors. The combination of microencapsulation and microcarrier technology resulted in a highly efficient protocol for the production and storage of pluripotent hESCs. This strategy ensured high expansion ratios (an approximately twenty-fold increase in cell concentration) and high cell recovery yields (>70%) after cryopreservation. When compared with non-encapsulated cells, cell survival post-thawing demonstrated a three-fold improvement without compromising hESC characteristics. Microencapsulation also improved the culture of hESC aggregates by protecting cells from hydrodynamic shear stress, controlling aggregate size and maintaining cell pluripotency for two weeks. This work establishes that microencapsulation technology may prove a powerful tool for integrating the expansion and cryopreservation of pluripotent hESCs. The 3D culture strategy developed herein represents a significant breakthrough towards the implementation of hESCs in clinical and industrial applications.

1 July 2015 in Journal of Biotechnology
Verified
Journal Article
Closed access
EMEva-Maria Materne
Eva-Maria Materne
ARAnja Patricia Ramme
Anja Patricia Ramme
ATAna Paula Terrasso
Ana Paula Terrasso
MSMargarida Serra
Margarida Serra
PAPaula M Alves
Paula M Alves
UMUwe Marx
Uwe Marx